ARISTADA COMENZA

Serial Number 87276114
606

Registration Progress

Application Filed
Dec 21, 2016
Under Examination
Apr 18, 2017
Approved for Publication
Feb 21, 2017
Published for Opposition
Feb 21, 2017
Registered

Trademark Image

ARISTADA COMENZA

Basic Information

Serial Number
87276114
Filing Date
December 21, 2016
Published for Opposition
February 21, 2017
Abandonment Date
June 8, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 8, 2020
Classes
005

Rights Holder

Alkermes Pharma Ireland Limited

03
Address
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4
IE

Ownership History

Alkermes Pharma Ireland Limited

Original Applicant
03
DUBLIN 4 IE

Alkermes Pharma Ireland Limited

Owner at Publication
03
DUBLIN 4 IE

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Jun 8, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 8, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 17, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 15, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 15, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 26, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 22, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 22, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 22, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 10, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 10, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 10, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 26, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 24, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 24, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 24, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 8, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 6, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 6, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 6, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 18, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 21, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 1, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 16, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 10, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 3, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 24, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005